Summary: Nyxoah SA has appointed Maurits S. Boon, MD, who is acknowledged for his get the job done in hypoglossal nerve stimulation remedy to deal with obstructive snooze apnea, as chief clinical officer. Boon, from Thomas Jefferson University, contributed to Nyxoah’s Desire US … [Read more...]
Nyxoah, AAO-HNSF to Enhance Access to Sleep Apnea Therapies
Nyxoah SA, maker of the CE-marked Genio neurostimulator for obstructive rest apnea (OSA), signed a strategic partnership to come to be a corporate winner at the Business Circle stage with the American Association of Otolaryngology – Head & Neck Surgery Basis (AAO-HNSF). Nyxoah … [Read more...]
Nyxoah Prepares to Unveil OSA Neurostimulation Study Results
Nyxoah SA announced the upcoming release of efficacy and safety data from the DREAM US pivotal study on the Genio neurostimulation system for obstructive sleep apnea (OSA). The results are expected by early April, according to the company’s fourth-quarter and full-year 2023 … [Read more...]